Dekaban G A, Oger J J, Foti D, King E E, Waters D J, Picard F J, Arp J, Werker D, Rice G P
Immunology Group, The John P. Robarts Research Institute, London, Ontario, Canada.
Clin Diagn Virol. 1994 Apr;2(2):67-78. doi: 10.1016/0928-0197(94)90039-6.
Recent epidemiology studies have demonstrated the presence of HTLV-I and its close relative, HTLV-II in several aboriginal populations in North, Central and South America but not in Canadian Indian populations. HTLV-II appears to be more prevalent than HTLV-I in aboriginal populations of the Americas. Recently several clinical cases of HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) and a case of adult T-cell leukemia (ATL) have been identified in British Columbian Indians. This data suggests that a new endemic area of HTLV-I infection may be present within British Columbian Indian population. However, it has recently been shown that HTLV-II may also be associated with a neurological disease similar to HAM/TSP.
The purpose of the work reported here was to demonstrate whether HTLV-I, HTLV-II or both were responsible for the diseases seen in the British Columbian Indians.
In this study serological and gene amplification techniques were used to determine whether HTLV-I or HTLV-II was present in four families and three unrelated individuals all from different bands of aboriginal Native Indians in British Columbia. In each family, one member had an HTLV-associated disease, three cases of HAM/TSP and one case of ATL. Of the three individual aboriginal natives unrelated to the four families, two had HAM/TSP while the third was asymptomatic for HTLV-associated diseases.
This study demonstrated the presence of HTLV-I in the aboriginal Indians with disease and in some of their family members. HTLV-II was not detected in any of the British Columbian Indians tested in this study.
These British Columbian Indians represent the first Canadian aboriginal Indians with HTLV-I infection and associated diseases. Furthermore, the British Columbian Indian population may represent a previously unrecognized endemic population of HTLV-I infection.
近期的流行病学研究表明,人类嗜T淋巴细胞病毒I型(HTLV-I)及其近亲人类嗜T淋巴细胞病毒II型(HTLV-II)在北美洲、中美洲和南美洲的几个原住民群体中存在,但在加拿大印第安人群体中未被发现。在美洲原住民群体中,HTLV-II似乎比HTLV-I更为普遍。最近,在不列颠哥伦比亚省的印第安人中发现了几例与HTLV-I相关的脊髓病/热带痉挛性截瘫(HAM/TSP)临床病例以及一例成人T细胞白血病(ATL)病例。这些数据表明,在不列颠哥伦比亚省的印第安人群体中可能存在一个新的HTLV-I感染流行区。然而,最近有研究表明,HTLV-II也可能与一种类似于HAM/TSP的神经系统疾病有关。
本文报道的研究目的是确定在不列颠哥伦比亚省印第安人中发现的疾病是由HTLV-I、HTLV-II还是两者共同引起的。
在本研究中,采用血清学和基因扩增技术来确定来自不列颠哥伦比亚省不同部落的四个家庭和三个无关个体中是否存在HTLV-I或HTLV-II。在每个家庭中,有一名成员患有与HTLV相关的疾病,其中三例为HAM/TSP,一例为ATL。在与这四个家庭无关的三名个体原住民中,两人患有HAM/TSP,第三人未出现与HTLV相关疾病的症状。
本研究证明,患有疾病的原住民印第安人及其一些家庭成员中存在HTLV-I。在本研究检测的所有不列颠哥伦比亚省印第安人中均未检测到HTLV-II。
这些不列颠哥伦比亚省印第安人是首批感染HTLV-I并患有相关疾病的加拿大原住民印第安人。此外,不列颠哥伦比亚省的印第安人群体可能代表了一个此前未被认识的HTLV-I感染流行人群。